Latest Organon News & Updates

See the latest news and media coverage for Organon. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Organon

Global healthcare company focused on women's health

organon.com
Headquarters
Jersey City, United States
Company type
Public company
Number of employees
10,000+

Last updated

Latest news about Organon

In short: Organon faced a potential $11.75 billion acquisition by Sun Pharma while reporting mixed financial results and securing several biosimilar approvals.

Company announcements

  • Organon

    EC approves Organon and Henlius's POHERDY biosimilar

    POHERDY is the first approved pertuzumab biosimilar in Europe for HER2-positive breast cancer treatments. It expands access via Organon's commercialization rights.

  • Organon

    Organon sells to Sun Pharma

    The sale is announced on April 26, 2026.

  • Organon

    Organon’s VTAMA cream receives strong AAD recommendation

    The 2026 guidelines endorse it as the only steroid-free topical for pediatric atopic dermatitis across severities in children aged 2+.

  • Organon

    Organon presents VTAMA Phase 3 data

    Data show early skin clearance and itch improvement in atopic dermatitis patients aged 2+ from ADORING trials at AAD 2026.

Unlock all announcements with a

Media coverage

Unlock all articles with a

Never miss news about Organon

Track Organon and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.